 | • レポートコード：MRC2Q12-16806 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、新生児疾患スクリーニングのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 新生児疾患スクリーニングのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 新生児疾患スクリーニングの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 新生児疾患スクリーニングのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの新生児疾患スクリーニングの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の新生児疾患スクリーニングの売上および2028年までの予測に焦点を当てています。 新生児疾患スクリーニングのグローバル主要企業には、AB Sciex、Agilent Technologies、Bio-Rad Laboratories、Cytiva、Masimo、Medtronic、Natus Medical、PerkinElmer、Zentech Manufacturingなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 新生児疾患スクリーニング市場は、タイプとアプリケーションによって区分されます。世界の新生児疾患スクリーニング市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 甲状腺機能低下症、フェニルケトン尿症、ガラクトース血症、鎌状赤血球症、その他 【アプリケーション別セグメント】 総合病院、専門クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 新生児疾患スクリーニング製品概要 - タイプ別市場（甲状腺機能低下症、フェニルケトン尿症、ガラクトース血症、鎌状赤血球症、その他） - アプリケーション別市場（総合病院、専門クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界の新生児疾患スクリーニング販売量予測2017-2028 - 世界の新生児疾患スクリーニング売上予測2017-2028 - 新生児疾患スクリーニングの地域別販売量 - 新生児疾患スクリーニングの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別新生児疾患スクリーニング販売量 - 主要メーカー別新生児疾患スクリーニング売上 - 主要メーカー別新生児疾患スクリーニング価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（甲状腺機能低下症、フェニルケトン尿症、ガラクトース血症、鎌状赤血球症、その他） - 新生児疾患スクリーニングのタイプ別販売量 - 新生児疾患スクリーニングのタイプ別売上 - 新生児疾患スクリーニングのタイプ別価格 ・アプリケーション別市場規模（総合病院、専門クリニック） - 新生児疾患スクリーニングのアプリケーション別販売量 - 新生児疾患スクリーニングのアプリケーション別売上 - 新生児疾患スクリーニングのアプリケーション別価格 ・北米市場 - 北米の新生児疾患スクリーニング市場規模（タイプ別、アプリケーション別） - 主要国別の新生児疾患スクリーニング市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの新生児疾患スクリーニング市場規模（タイプ別、アプリケーション別） - 主要国別の新生児疾患スクリーニング市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の新生児疾患スクリーニング市場規模（タイプ別、アプリケーション別） - 主要国別の新生児疾患スクリーニング市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の新生児疾患スクリーニング市場規模（タイプ別、アプリケーション別） - 主要国別の新生児疾患スクリーニング市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの新生児疾患スクリーニング市場規模（タイプ別、アプリケーション別） - 主要国別の新生児疾患スクリーニング市場規模（トルコ、サウジアラビア） ・企業情報 AB Sciex、Agilent Technologies、Bio-Rad Laboratories、Cytiva、Masimo、Medtronic、Natus Medical、PerkinElmer、Zentech Manufacturing ・産業チェーン及び販売チャネル分析 - 新生児疾患スクリーニングの産業チェーン分析 - 新生児疾患スクリーニングの原材料 - 新生児疾患スクリーニングの生産プロセス - 新生児疾患スクリーニングの販売及びマーケティング - 新生児疾患スクリーニングの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 新生児疾患スクリーニングの産業動向 - 新生児疾患スクリーニングのマーケットドライバー - 新生児疾患スクリーニングの課題 - 新生児疾患スクリーニングの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Newborn Disease Screening estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Newborn Disease Screening is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Newborn Disease Screening is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Newborn Disease Screening is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Newborn Disease Screening include AB Sciex, Agilent Technologies, Bio-Rad Laboratories, Cytiva, Masimo, Medtronic, Natus Medical, PerkinElmer and Zentech Manufacturing, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Newborn Disease Screening companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Newborn Disease Screening market. Further, it explains the major drivers and regional dynamics of the global Newborn Disease Screening market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
AB Sciex
Agilent Technologies
Bio-Rad Laboratories
Cytiva
Masimo
Medtronic
Natus Medical
PerkinElmer
Zentech Manufacturing
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Newborn Disease Screening Segment by Type
Hypothyroidism
Phenylketonuria
Galactosemia
Sickle Cell Disease
Others
Newborn Disease Screening Segment by Application
General Hospitals
Specialty Clinics
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Newborn Disease Screening market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Newborn Disease Screening market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Newborn Disease Screening, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Newborn Disease Screening, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Newborn Disease Screening revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Newborn Disease Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Newborn Disease Screening revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AB Sciex, Agilent Technologies, Bio-Rad Laboratories, Cytiva, Masimo, Medtronic, Natus Medical, PerkinElmer and Zentech Manufacturing, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Newborn Disease Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Disease Screening companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newborn Disease Screening revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Disease Screening Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hypothyroidism
1.2.3 Phenylketonuria
1.2.4 Galactosemia
1.2.5 Sickle Cell Disease
1.2.6 Others
1.3 Market by Application
1.3.1 Global Newborn Disease Screening Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Newborn Disease Screening Market Perspective (2017-2028)
2.2 Newborn Disease Screening Growth Trends by Region
2.2.1 Newborn Disease Screening Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Newborn Disease Screening Historic Market Size by Region (2017-2022)
2.2.3 Newborn Disease Screening Forecasted Market Size by Region (2023-2028)
2.3 Newborn Disease Screening Market Dynamics
2.3.1 Newborn Disease Screening Industry Trends
2.3.2 Newborn Disease Screening Market Drivers
2.3.3 Newborn Disease Screening Market Challenges
2.3.4 Newborn Disease Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Disease Screening Players by Revenue
3.1.1 Global Top Newborn Disease Screening Players by Revenue (2017-2022)
3.1.2 Global Newborn Disease Screening Revenue Market Share by Players (2017-2022)
3.2 Global Newborn Disease Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn Disease Screening Revenue
3.4 Global Newborn Disease Screening Market Concentration Ratio
3.4.1 Global Newborn Disease Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Disease Screening Revenue in 2021
3.5 Newborn Disease Screening Key Players Head office and Area Served
3.6 Key Players Newborn Disease Screening Product Solution and Service
3.7 Date of Enter into Newborn Disease Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Disease Screening Breakdown Data by Type
4.1 Global Newborn Disease Screening Historic Market Size by Type (2017-2022)
4.2 Global Newborn Disease Screening Forecasted Market Size by Type (2023-2028)
5 Newborn Disease Screening Breakdown Data by Application
5.1 Global Newborn Disease Screening Historic Market Size by Application (2017-2022)
5.2 Global Newborn Disease Screening Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Newborn Disease Screening Market Size (2017-2028)
6.2 North America Newborn Disease Screening Market Size by Type
6.2.1 North America Newborn Disease Screening Market Size by Type (2017-2022)
6.2.2 North America Newborn Disease Screening Market Size by Type (2023-2028)
6.2.3 North America Newborn Disease Screening Market Share by Type (2017-2028)
6.3 North America Newborn Disease Screening Market Size by Application
6.3.1 North America Newborn Disease Screening Market Size by Application (2017-2022)
6.3.2 North America Newborn Disease Screening Market Size by Application (2023-2028)
6.3.3 North America Newborn Disease Screening Market Share by Application (2017-2028)
6.4 North America Newborn Disease Screening Market Size by Country
6.4.1 North America Newborn Disease Screening Market Size by Country (2017-2022)
6.4.2 North America Newborn Disease Screening Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Newborn Disease Screening Market Size (2017-2028)
7.2 Europe Newborn Disease Screening Market Size by Type
7.2.1 Europe Newborn Disease Screening Market Size by Type (2017-2022)
7.2.2 Europe Newborn Disease Screening Market Size by Type (2023-2028)
7.2.3 Europe Newborn Disease Screening Market Share by Type (2017-2028)
7.3 Europe Newborn Disease Screening Market Size by Application
7.3.1 Europe Newborn Disease Screening Market Size by Application (2017-2022)
7.3.2 Europe Newborn Disease Screening Market Size by Application (2023-2028)
7.3.3 Europe Newborn Disease Screening Market Share by Application (2017-2028)
7.4 Europe Newborn Disease Screening Market Size by Country
7.4.1 Europe Newborn Disease Screening Market Size by Country (2017-2022)
7.4.2 Europe Newborn Disease Screening Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Disease Screening Market Size (2017-2028)
8.2 Asia-Pacific Newborn Disease Screening Market Size by Type
8.2.1 Asia-Pacific Newborn Disease Screening Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Newborn Disease Screening Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Newborn Disease Screening Market Share by Type (2017-2028)
8.3 Asia-Pacific Newborn Disease Screening Market Size by Application
8.3.1 Asia-Pacific Newborn Disease Screening Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Newborn Disease Screening Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Newborn Disease Screening Market Share by Application (2017-2028)
8.4 Asia-Pacific Newborn Disease Screening Market Size by Region
8.4.1 Asia-Pacific Newborn Disease Screening Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Newborn Disease Screening Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Newborn Disease Screening Market Size (2017-2028)
9.2 Latin America Newborn Disease Screening Market Size by Type
9.2.1 Latin America Newborn Disease Screening Market Size by Type (2017-2022)
9.2.2 Latin America Newborn Disease Screening Market Size by Type (2023-2028)
9.2.3 Latin America Newborn Disease Screening Market Share by Type (2017-2028)
9.3 Latin America Newborn Disease Screening Market Size by Application
9.3.1 Latin America Newborn Disease Screening Market Size by Application (2017-2022)
9.3.2 Latin America Newborn Disease Screening Market Size by Application (2023-2028)
9.3.3 Latin America Newborn Disease Screening Market Share by Application (2017-2028)
9.4 Latin America Newborn Disease Screening Market Size by Country
9.4.1 Latin America Newborn Disease Screening Market Size by Country (2017-2022)
9.4.2 Latin America Newborn Disease Screening Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Disease Screening Market Size (2017-2028)
10.2 Middle East & Africa Newborn Disease Screening Market Size by Type
10.2.1 Middle East & Africa Newborn Disease Screening Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Newborn Disease Screening Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Newborn Disease Screening Market Share by Type (2017-2028)
10.3 Middle East & Africa Newborn Disease Screening Market Size by Application
10.3.1 Middle East & Africa Newborn Disease Screening Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Newborn Disease Screening Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Newborn Disease Screening Market Share by Application (2017-2028)
10.4 Middle East & Africa Newborn Disease Screening Market Size by Country
10.4.1 Middle East & Africa Newborn Disease Screening Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Newborn Disease Screening Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Sciex
11.1.1 AB Sciex Company Details
11.1.2 AB Sciex Business Overview
11.1.3 AB Sciex Newborn Disease Screening Introduction
11.1.4 AB Sciex Revenue in Newborn Disease Screening Business (2017-2022)
11.1.5 AB Sciex Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Newborn Disease Screening Introduction
11.2.4 Agilent Technologies Revenue in Newborn Disease Screening Business (2017-2022)
11.2.5 Agilent Technologies Recent Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Newborn Disease Screening Introduction
11.3.4 Bio-Rad Laboratories Revenue in Newborn Disease Screening Business (2017-2022)
11.3.5 Bio-Rad Laboratories Recent Developments
11.4 Cytiva
11.4.1 Cytiva Company Details
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Newborn Disease Screening Introduction
11.4.4 Cytiva Revenue in Newborn Disease Screening Business (2017-2022)
11.4.5 Cytiva Recent Developments
11.5 Masimo
11.5.1 Masimo Company Details
11.5.2 Masimo Business Overview
11.5.3 Masimo Newborn Disease Screening Introduction
11.5.4 Masimo Revenue in Newborn Disease Screening Business (2017-2022)
11.5.5 Masimo Recent Developments
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Newborn Disease Screening Introduction
11.6.4 Medtronic Revenue in Newborn Disease Screening Business (2017-2022)
11.6.5 Medtronic Recent Developments
11.7 Natus Medical
11.7.1 Natus Medical Company Details
11.7.2 Natus Medical Business Overview
11.7.3 Natus Medical Newborn Disease Screening Introduction
11.7.4 Natus Medical Revenue in Newborn Disease Screening Business (2017-2022)
11.7.5 Natus Medical Recent Developments
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Newborn Disease Screening Introduction
11.8.4 PerkinElmer Revenue in Newborn Disease Screening Business (2017-2022)
11.8.5 PerkinElmer Recent Developments
11.9 Zentech Manufacturing
11.9.1 Zentech Manufacturing Company Details
11.9.2 Zentech Manufacturing Business Overview
11.9.3 Zentech Manufacturing Newborn Disease Screening Introduction
11.9.4 Zentech Manufacturing Revenue in Newborn Disease Screening Business (2017-2022)
11.9.5 Zentech Manufacturing Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer